These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19916323)

  • 21. Regulation of insulin sensitivity by adiponectin and its receptors in response to physical exercise.
    Passos MC; Gonçalves MC
    Horm Metab Res; 2014 Aug; 46(9):603-8. PubMed ID: 25126860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes.
    Bermúdez VJ; Rojas E; Toledo A; Rodríguez-Molina D; Vega K; Suárez L; Pacheco M; Canelón R; Arráiz N; Rojas J; Velasco M
    Am J Ther; 2013; 20(4):414-21. PubMed ID: 23656997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.
    van Stijn CM; Kim J; Lusis AJ; Barish GD; Tangirala RK
    FASEB J; 2015 Feb; 29(2):636-49. PubMed ID: 25392268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice.
    Fu L; Isobe K; Zeng Q; Suzukawa K; Takekoshi K; Kawakami Y
    Eur J Pharmacol; 2008 Apr; 584(1):202-6. PubMed ID: 18304529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor.
    Clark JL; Taylor CG; Zahradka P
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):200-206. PubMed ID: 28820074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes.
    Kennedy DJ; Kashyap SR
    Metab Syndr Relat Disord; 2011 Aug; 9(4):239-45. PubMed ID: 21428745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in adipokines.
    Sahin-Efe A; Katsikeris F; Mantzoros CS
    Metabolism; 2012 Dec; 61(12):1659-65. PubMed ID: 23021039
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation.
    Jialal I; Adams-Huet B; Duong F; Smith G
    Metab Syndr Relat Disord; 2014 May; 12(4):227-30. PubMed ID: 24593134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin, the past two decades.
    Wang ZV; Scherer PE
    J Mol Cell Biol; 2016 Apr; 8(2):93-100. PubMed ID: 26993047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
    Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
    Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
    Gable DR; Hurel SJ; Humphries SE
    Atherosclerosis; 2006 Oct; 188(2):231-44. PubMed ID: 16581078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China.
    Li X; Ren N; Ling W; Chen F; Zhang W; Fan X; Tian M; Zhang T; Li B; Pfeffer LM; Wu H; Zhang J
    Hepatogastroenterology; 2012 Sep; 59(118):1735-43. PubMed ID: 22819899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome.
    Seetho IW; Wilding JP
    Chron Respir Dis; 2014 Nov; 11(4):257-75. PubMed ID: 25281562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.
    Xu X; Lu L; Dong Q; Li X; Zhang N; Xin Y; Xuan S
    Lipids Health Dis; 2015 Dec; 14():158. PubMed ID: 26631018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of adiponectin system in insulin resistance.
    Caselli C
    Mol Genet Metab; 2014 Nov; 113(3):155-60. PubMed ID: 25242063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin and its association with insulin resistance and type 2 diabetes.
    Sheng T; Yang K
    J Genet Genomics; 2008 Jun; 35(6):321-6. PubMed ID: 18571119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adiponectin--a key adipokine in the metabolic syndrome.
    Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
    Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.